Finally, we were able to show that NSGS‐engrafting MPN cells preferentally reside in the CD34+/CD38− subfraction of the clone, contrasting post‐MPN sAML, where both the CD34+/CD38− and CD34+/CD38+ subfractions engrafted in NSGS mice. This evidence concerns the gene CD34 and myeloproliferative disorder.